We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 116

Don't forget: FDA frequents Facebook
  • Reed Smith LLP
  • USA, Switzerland
  • March 14 2014

In only the second Untitled Letter of the year, FDA's Office of Prescription Drug Promotion warned a Swiss drug company about statements the company


Thomas Kreifels
  • Freshfields Bruckhaus Deringer

Celia M. Joseph
  • Fisher Phillips

Sally Albertazzie
  • Steptoe & Johnson LLP

John Blain
  • Freshfields Bruckhaus Deringer